Trial intelligence / Profile preview

SPICE IV older ventilated ICU patients

NL-OMON61006Phase 4Completed

Sponsor
Monash University
Start
Feb 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in critical illness, sponsored by Monash University. Started Feb 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

critical illness

Beyond the preview

Go deeper on NL-OMON61006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON61006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call